AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 47 filers reported holding AUTOLUS THERAPEUTICS PLC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $55 | +1275.0% | 15,868 | +2659.7% | 0.00% | – |
| Q1 2024 | $4 | 0.0% | 575 | 0.0% | 0.00% | – |
| Q4 2023 | $4 | – | 575 | +677.0% | 0.00% | – |
| Q3 2022 | $0 | – | 74 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 74 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 74 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 74 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | – | 74 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | – | 74 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 74 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | -50.0% | 74 | -56.0% | 0.00% | – |
| Q3 2020 | $2,000 | +100.0% | 168 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 168 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | -50.0% | 168 | 0.0% | 0.00% | – |
| Q4 2019 | $2,000 | 0.0% | 168 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | 0.0% | 168 | +46.1% | 0.00% | – |
| Q2 2019 | $2,000 | -50.0% | 115 | 0.0% | 0.00% | – |
| Q1 2019 | $4,000 | -42.9% | 115 | -42.5% | 0.00% | – |
| Q4 2018 | $7,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 7,346,829 | $15,723,000 | 27.32% |
| TFG Asset Management GP Ltd | 3,039,381 | $6,504,000 | 0.78% |
| Nantahala Capital Management | 5,215,788 | $11,162,000 | 0.72% |
| Frazier Life Sciences Management, L.P. | 3,746,857 | $8,018,000 | 0.62% |
| HARBOR CAPITAL ADVISORS, INC. | 148,454 | $318,000 | 0.29% |
| DAFNA Capital Management LLC | 496,150 | $1,062,000 | 0.29% |
| Blackstone Inc. | 17,985,611 | $38,489 | 0.14% |
| Ikarian Capital, LLC | 260,087 | $556,000 | 0.11% |
| MYDA Advisors LLC | 100,000 | $214,000 | 0.10% |
| Privium Fund Management B.V. | 113,528 | $253,000 | 0.09% |